A review of the statistical analysis of randomised controlled trials conducted within OCTRU.
Ooms A. et al, (2025), Trials, 26
External validation of a prognostic model to improve prediction of psychosis: a retrospective cohort study in primary care.
Sullivan SA. et al, (2024), Br j gen pract
SIGNET: protocol for a multicentre, single-blind prospective, group sequential, randomised controlled trial to evaluate the benefits of a single dose of simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients.
Evans A. et al, (2024), Bmj open, 14
Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double-blind, placebo-controlled feasibility trial.
Desborough MJR. et al, (2024), Ejhaem, 5, 772 - 777
Defatting of donor transplant livers during normothermic perfusion-a randomised clinical trial: study protocol for the DeFat study.
Abbas SH. et al, (2024), Trials, 25
Overcoming the challenges of delivering a national randomised controlled trial in organ donation
Harvey D. et al, (2023), Transplantation, 107, 40 - 40
Childhood trajectories of internalising and externalising problems associated with a polygenic risk score for neuroticism in a UK birth cohort study.
Costantini I. et al, (2023), Jcpp adv, 3
The impact of routines on emotional and behavioural difficulties in children and on parental anxiety during COVID-19.
Lees V. et al, (2023), Front child adolesc psychiatry, 2
Developing and internally validating a prognostic model (P Risk) to improve the prediction of psychosis in a primary care population using electronic health records: The MAPPED study.
Sullivan SA. et al, (2022), Schizophrenia research, 246, 241 - 249
How much change is enough? Evidence from a longitudinal study on depression in UK primary care
Kounali D. et al, (2022), Psychological medicine, 52, 1875 - 1882
Is there a role for Desmopressin as an alternative to platelet transfusion prior to procedures or Radiological InterVEntions in thrombocytopenic critically ill patients (DRIVE)? Results of a randomised double-blind placebo-controlled feasibility trial
Desborough M. et al, (2022), British journal of haematology, 197, 40 - 41
Precursors and correlates of transient and persistent longitudinal profiles of psychotic experiences from late childhood through early adulthood.
Rammos A. et al, (2021), Br j psychiatry, 1 - 9
Phenotypic manifestations of genetic liability to neuroticism across childhood: a UK prospective birth cohort study
Costantini I. et al, (2021), Abstracts of the virtual world congress of psychiatric genetics (wcpg), october 11 - 15 2021, 51, e43 - e44
Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials
Bauer-Staeb C. et al, (2021), Journal of clinical epidemiology, 137, 200 - 208
Comparison between self-administered depression questionnaires and patients' own views of changes in their mood: a prospective cohort study in primary care.
Hobbs C. et al, (2021), Psychological medicine, 51, 853 - 860
S134. INCIDENCE, IMPACT AND TRAJECTORIES OF PSYCHOTIC EXPERIENCES FROM CHILDHOOD TO ADULTHOOD, AND PREDICTION OF PSYCHOTIC DISORDER
Zammit S. et al, (2020), Schizophrenia bulletin: the journal of psychoses and related disorders, 46, s86 - s86
A Population-Based Cohort Study Examining the Incidence and Impact of Psychotic Experiences From Childhood to Adulthood, and Prediction of Psychotic Disorder.
Sullivan SA. et al, (2020), Am j psychiatry, 177, 308 - 317
INCIDENCE, IMPACT AND TRAJECTORIES OF PSYCHOTIC EXPERIENCES FROM CHILDHOOD TO ADULTHOOD, AND PREDICTION OF PSYCHOTIC DISORDER
Zammit S. et al, (2020), Schizophrenia bulletin, 46, S86 - S86